Ohad Mazor

1.8k total citations
52 papers, 988 citations indexed

About

Ohad Mazor is a scholar working on Immunology, Molecular Biology and Biotechnology. According to data from OpenAlex, Ohad Mazor has authored 52 papers receiving a total of 988 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 18 papers in Molecular Biology and 17 papers in Biotechnology. Recurrent topics in Ohad Mazor's work include Toxin Mechanisms and Immunotoxins (16 papers), Transgenic Plants and Applications (12 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Ohad Mazor is often cited by papers focused on Toxin Mechanisms and Immunotoxins (16 papers), Transgenic Plants and Applications (12 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Ohad Mazor collaborates with scholars based in Israel, Italy and France. Ohad Mazor's co-authors include Yoram Salomon, Avigdor Scherz, Chanoch Kronman, Eran Neumark, V. Rosenbach‐Belkin, Alexander Brandis, Ron Alcalay, Ofer Cohen, Adva Mechaly and Tamar Sabo and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Ohad Mazor

51 papers receiving 968 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ohad Mazor Israel 20 308 291 278 261 216 52 988
Shannon Wing‐Ngor Au Hong Kong 21 120 0.4× 947 3.3× 237 0.9× 111 0.4× 90 0.4× 36 1.6k
Ruifang Wang China 21 109 0.4× 354 1.2× 193 0.7× 145 0.6× 24 0.1× 80 1.3k
Masayuki Ohara Japan 18 87 0.3× 985 3.4× 52 0.2× 144 0.6× 57 0.3× 34 1.4k
Kiyoshi Miwa Japan 25 65 0.2× 902 3.1× 666 2.4× 84 0.3× 81 0.4× 84 1.8k
Kurt Zimmermann Germany 24 190 0.6× 780 2.7× 79 0.3× 69 0.3× 101 0.5× 66 1.7k
Xin Hu China 20 51 0.2× 551 1.9× 122 0.4× 102 0.4× 53 0.2× 67 1.2k
Krishan Kumar India 18 79 0.3× 667 2.3× 55 0.2× 62 0.2× 84 0.4× 53 1.3k
Megan Garland United States 15 60 0.2× 408 1.4× 56 0.2× 178 0.7× 40 0.2× 21 899
Jinming Zhou China 24 155 0.5× 846 2.9× 387 1.4× 47 0.2× 24 0.1× 110 1.9k

Countries citing papers authored by Ohad Mazor

Since Specialization
Citations

This map shows the geographic impact of Ohad Mazor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ohad Mazor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ohad Mazor more than expected).

Fields of papers citing papers by Ohad Mazor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ohad Mazor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ohad Mazor. The network helps show where Ohad Mazor may publish in the future.

Co-authorship network of co-authors of Ohad Mazor

This figure shows the co-authorship network connecting the top 25 collaborators of Ohad Mazor. A scholar is included among the top collaborators of Ohad Mazor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ohad Mazor. Ohad Mazor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tamir, Hadas, Tal Noy-Porat, Sharon Melamed, et al.. (2024). Synergistic effect of two human-like monoclonal antibodies confers protection against orthopoxvirus infection. Nature Communications. 15(1). 3265–3265. 10 indexed citations
2.
Levy, Yinon, Ron Alcalay, Anat Zvi, et al.. (2022). Immunodominant Linear B-Cell Epitopes of SARS-CoV-2 Spike, Identified by Sera from K18-hACE2 Mice Infected with the WT or Variant Viruses. Vaccines. 10(2). 251–251. 4 indexed citations
3.
Mechaly, Adva, Ron Alcalay, Eyal Epstein, et al.. (2022). Highly Specific Monoclonal Antibody Targeting the Botulinum Neurotoxin Type E Exposed SNAP-25 Neoepitope. Antibodies. 11(1). 21–21. 5 indexed citations
4.
Rosenfeld, Ronit, Ron Alcalay, Anat Zvi, et al.. (2022). Centaur antibodies: Engineered chimeric equine-human recombinant antibodies. Frontiers in Immunology. 13. 942317–942317. 4 indexed citations
5.
Noy-Porat, Tal, Ron Alcalay, Adva Mechaly, et al.. (2021). Characterization of antibody-antigen interactions using biolayer interferometry. STAR Protocols. 2(4). 100836–100836. 17 indexed citations
6.
Dachir, Shlomit, et al.. (2021). Extended retrospective detection of regenerated sarin (GB) in rabbit blood and the IMPA metabolite in urine: a pharmacokinetics study. Archives of Toxicology. 95(7). 2403–2412. 2 indexed citations
7.
Falach, Reut, Anita Sapoznikov, Yoav Gal, et al.. (2020). The low density receptor-related protein 1 plays a significant role in ricin-mediated intoxication of lung cells. Scientific Reports. 10(1). 9007–9007. 2 indexed citations
8.
Rosenfeld, Ronit, Ron Alcalay, Adva Mechaly, et al.. (2017). Improved antibody-based ricin neutralization by affinity maturation is correlated with slower off-rate values. Protein Engineering Design and Selection. 30(9). 611–617. 17 indexed citations
9.
Noy-Porat, Tal, Ron Alcalay, Eyal Epstein, et al.. (2017). Extended therapeutic window for post-exposure treatment of ricin intoxication conferred by the use of high-affinity antibodies. Toxicon. 127. 100–105. 17 indexed citations
10.
Mechaly, Adva, Hagai Cohen, Ofer Cohen, & Ohad Mazor. (2016). A biolayer interferometry-based assay for rapid and highly sensitive detection of biowarfare agents. Analytical Biochemistry. 506. 22–27. 33 indexed citations
11.
Gal, Yoav, Ron Alcalay, Tamar Sabo, et al.. (2015). Rapid assessment of antibody-induced ricin neutralization by employing a novel functional cell-based assay. Journal of Immunological Methods. 424. 136–139. 11 indexed citations
12.
Gal, Yoav, Ohad Mazor, Ron Alcalay, et al.. (2014). Antibody/doxycycline combined therapy for pulmonary ricinosis: Attenuation of inflammation improves survival of ricin-intoxicated mice. Toxicology Reports. 1. 496–504. 42 indexed citations
13.
Cohen, Ofer, Adva Mechaly, Tamar Sabo, et al.. (2014). Characterization and Epitope Mapping of the Polyclonal Antibody Repertoire Elicited by Ricin Holotoxin-Based Vaccination. Clinical and Vaccine Immunology. 21(11). 1534–1540. 20 indexed citations
14.
Mechaly, Adva, et al.. (2014). Rapid Homogenous Time-Resolved Fluorescence (HTRF) Immunoassay for Anthrax Detection. Journal of Fluorescence. 24(3). 795–801. 13 indexed citations
15.
Kronman, Chanoch, Ofer Cohen, Lily Raveh, et al.. (2006). Polyethylene-glycol conjugated recombinant human acetylcholinesterase serves as an efficacious bioscavenger against soman intoxication. Toxicology. 233(1-3). 40–46. 21 indexed citations
16.
Brandis, Alexander, Ohad Mazor, Eran Neumark, et al.. (2005). Novel water-soluble bacteriochlorophyll derivatives for vascular-targeted photodynamic therapy: synthesis, solubility, phototoxicity, and the effect of serum proteins. Photochemistry and Photobiology. 29 indexed citations
17.
Plaks, Vicki, et al.. (2004). Homologous Adaptation to Oxidative Stress Induced by the Photosensitized Pd-bacteriochlorophyll Derivative (WST11) in Cultured Endothelial Cells. Journal of Biological Chemistry. 279(44). 45713–45720. 12 indexed citations
18.
19.
Mazor, Ohad, et al.. (2003). Bypass of Tumor Drug Resistance by Antivascular Therapy. Neoplasia. 5(6). 475–480. 31 indexed citations
20.
Mazor, Ohad, Alain Lombet, Anne Gruaz‐Guyon, et al.. (2002). Europium-Labeled Epidermal Growth Factor and Neurotensin: Novel Probes for Receptor-Binding Studies. Analytical Biochemistry. 301(1). 75–81. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shannon Wing‐Ngor Au Breakdown of academic impact, for papers by Ruifang Wang Breakdown of academic impact, for papers by Masayuki Ohara Breakdown of academic impact, for papers by Kiyoshi Miwa Breakdown of academic impact, for papers by Kurt Zimmermann Breakdown of academic impact, for papers by Xin Hu Breakdown of academic impact, for papers by Krishan Kumar Breakdown of academic impact, for papers by Megan Garland Breakdown of academic impact, for papers by Jinming Zhou
Rankless by CCL
2026